Pediatric patients with critical illness experience high rates of hyperglycemia while hospitalized in the intensive care unit. Almost 90% of children undergoing cardiac surgery develop hyperglycemia in the post-operative period. [1] [2] [3] [4] Previous observational studies provide conflicting evidence about the association between hyperglycemia and morbidity and mortality in these patients. 3, [5] [6] [7] Data from adult cardiac surgical populations 8 suggested the need for an experimental trial to determine whether post-operative tight glycemic control (TGC) with insulin therapy provided benefit over standard blood glucose management. We previously reported the results of the Safe Pediatric Euglycemia after Cardiac Surgery (SPECS) trial 9 where we compared TGC to standard care (STD) in patients from birth to 36 months undergoing cardiac surgery with cardiopulmonary bypass, and showed that TGC did not reduce the incidence of post-operative healthcare-associated infections or mortality.
Though we found no differences between the treatment and standard care groups in the SPECS trial, it remains possible that heterogeneity of treatment effect exists across the study population; both the effectiveness and safety of the treatment can vary between patients with different risks for the primary outcome and treatment harm. 10 Therefore, we aimed to investigate whether there were differential effects of TGC on outcomes in certain identifiable subgroups within the SPECS trial cohort. We focused this analysis on subgroups believed a priori to be at higher risk for infections and other morbidities. The results of this exploratory analysis are meant to inform subsequent research on TGC in critically ill children so that conflicting evidence and remaining knowledge gaps can be specifically addressed in future experimental trials and meta-analyses.
Methods
The present study is a post-hoc analysis of the SPECS study database: the SPECS trial methods, urgery with cardiopulmonary bypass, and showed that TGC did not re d duce the i in nc ncid id i en en nce ce ce o o of f f post-operative healthcare-associated infections or mortality.
Th Th Thou ou o g g gh w w we e e fo f und no differences between en n th h he treatment an n nd d st tan an nd da dard care groups in the S SP SPE EC ECS trial, i it t re re em ma main in ins po po pos ss ssib ib ibl le le t tha ha hat t t h he et te erog ge gen neit ty y o of t t tre re eat atme me ment nt e ef ff fec ect t ex ex exis sts ts s a a acr cros os ss th th the e e st st tud d udy y y po popu pu pula la lati tion on; ; ; bo bo b th th th he he e eff ffe ec ecti t ve ve ene ne ess ss ss an a and d sa sa afe fe fety ty ty o o of f f th th he e tr t e e eatm tm tme en ent t t ca ca c n n n v v var ar a y y y be e etw tw wee ee e n n n pa pa pati ti tien nt t ts w w wit ith h h n different risk ks s s fo fo for r th th the e pr pr prim im mar ar a y y y ou ou outc tc t om om ome e e an an and d d tr tr trea ea eatm tm men en ent t ha ha arm rm rm. 10 10 10 Th Th T er er eref ef for or ore, e, e, w w we e ai ai aime me med d d to to t statistical analysis plan, and results have been published previously. 9, 11 The SPECS trial (ClinicalTrials.gov number NCT00443599) was a two-center, randomized, controlled trial that enrolled 980 children from birth to 36 months at the time of surgery with cardiopulmonary bypass who received post-operative care in the cardiac intensive care unit (CICU) at either Boston Children's Hospital or the University of Michigan C.S. Mott Children's Hospital.
Patients were randomized to receive either TGC (targeting normoglycemia; 80 to 110 mg/dL [4.4 to 6.1 mmol/L]) or STD during their recovery in the CICU. Insulin infusions were used to maintain blood glucose levels in the TGC group and doses were titrated according to a
proportional-integral-derivative algorithm, which is modeled on beta cell physiology. 12, 13 Both treatment groups were monitored with subcutaneous continuous glucose monitors to assist in glucose control and avoidance of hypoglycemia.
The primary outcome for the trial was incidence of 30-day healthcare-associated infections, which included pneumonia, bloodstream, urinary tract, and surgical site infections, as defined by Centers for Disease Control and Prevention (CDC), per 1,000 CICU days.
14 Secondary outcomes included mortality, cardiac index, duration of vasoactive support and mechanical ventilation, and CICU length of stay. Cardiac index was determined on postoperative day 2 in patients who were mechanically ventilated, sedated, and had a superior vena cava or pulmonary artery catheter in situ. We calculated cardiac index by the Fick principle using oxygen consumption (VO 2 ) measured by indirect calorimetry, hemoglobin concentration, and the difference between arterial and mixed venous oxygen saturation, as previously validated. 15 In the overall cohort, there was no treatment effect identified in any of the primary or secondary outcomes. 9 To compare infection rates of SPECS subjects to historical trends we compiled infection reatment groups were monitored with subcutaneous continuous glucose monito ors rs t to o o as as ssi si sist st st i i in n n glucose control and avoidance of hypoglycemia.
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data for children less than 3 years of age who were admitted to the Boston Children's Hospital CICU after cardiopulmonary bypass surgery but who did not participate in SPECS. All patients meeting these criteria between 1/1/2005 and 12/31/2012 were included. Infections in non-study patients were defined according to the same CDC criteria used in SPECS and were adjudicated by the same individuals.
The study was approved by the institutional review boards at both Boston Children's
Hospital and the University of Michigan CS Mott Children's Hospital. Parents and/or guardians of the patients gave written informed consent.
Statistical analysis
We previously reported pre-specified, high-risk subgroup analyses for patients with a Risk Adjustment in Congenital Heart Surgery (RACHS-1) category 16 of 3 or higher (or not assignable), or a length of stay in the CICU of 3 days or longer; the latter analysis was based on a post-randomization factor. 9 We subsequently performed several stratified post-hoc analyses to determine whether TGC had a differential effect on infection incidence in seven other specific subgroups of the patient cohort. Based on chance alone, we would expect that 0.35 tests out of 7 tests for interaction would be statistically significant at the P<0.05 level. The variables used for stratification were those that identified certain subgroups at greater risk of infection and other post-operative morbidities. Seven risk factors present prior to protocol initiation were considered: 1) age at surgery ( 30 vs. >30 days), 2) previous cardiac surgery, 3) chromosomal anomaly, 4) intraoperative glucocorticoid therapy, 5) non-biologic surgical implant used for repair, 6) delayed sternal closure, and 7) first post-operative blood glucose ( 110 vs. <110 mg/dL). Some of these variables -for example, surgical complexity and delayed sternal closure -have been associated with increased risk of healthcare-associated infection in prior analyses, 17- We previously reported pre-specified, high-risk subgroup analyses for pa k tients w w wit i ith h h a R Ri Risk sk sk Adjustment in Congenital Heart Surgery (RACHS-1) category 16 of 3 or higher (or not as ssi si ign gn gnab ab able le le), ), ), o o or a a le le leng n th of stay in the CICU of 3 3 d d da ay ys or longer; t the h h lat at tte te ter r r analysis was based on a post st t-randomiza zati ti tion n f f fa ac acto to or. r 9 9 9 We W We s s sub ub ubse e eq qu uen nt tly y y pe erf rfo orme me med d se sev ve vera ra al st stra rati ti tifi ied ed p p po os ost-t-ho ho hoc c c an an nal l ly ys yse e es t t to de dete te term rm min ine e wh wh whet eth he her r r TG TG GC C C ha had d a a di di diff ff ffer e eren en nti tial al al e e eff ffec ec ect t on on on in nf nfec ec cti ti tion on on i i inc nc ncid d den en ence ce e i i in n se se eve ve en n o ot oth h her r sp p pec ecif if fic c ubgroups of f t t the he he p p pat at atie ie ent nt nt coh oh ohor or o t. . . Ba Ba Base se s d d d on on n c c cha ha hanc nc n e e e al al alon on o e, e, e, w w we e e wo wo woul u u d d d ex ex expe pe pect ct ct th th t at at t 0 0 0. Within a subgroup, the effect of tight glycemic control on infection was assessed with the use of odds ratios and exact 95% confidence intervals derived from conditional logistic regression. Potential differential effects of TGC on infection across subgroups were analyzed with the use of exact logistic regression that included the interaction between treatment group and risk factor after including both as main effects. Given the observed heterogeneity of treatment effect by age at surgery, we explored logistic regression models that included the effects of treatment group, age subgroup, and their interaction, using different age cutoffs. We then used maximum likelihood and a likelihood ratio test-based confidence interval to select an optimal age cutoff. Using this optimal age cutoff we then assessed the potential differential effects of TGC on other outcomes across age subgroups using exact logistic regression for binary outcomes, exact Poisson regression for count outcomes or rates, Cox proportional hazards regression for time-to-event outcomes, and linear regression for continuous outcomes. To explore other potential predictors of infection, multivariable stepwise logistic regression was used. Infections rates in non-study patients 60 days old were compared to rates in non-study patients >60 days old using exact Poisson regression. All reported P values are two-sided.
Statistical analyses were performed with the use of SAS software, version 9.3. The reporting of results below follows the "Guidelines for Reporting Subgroup Analysis".
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Results
All 980 subjects from the original SPECS trial were included in the analyses. Table 1 displays the proportion of subjects with any 30-day healthcare-associated infection and the odds ratio hen used maximum likelihood and a likelihood ratio test-based confidence interv rv val al l t to o se se sele le lect ct ct a an n optimal age cutoff. Using this optimal age cutoff we then assessed the potential differential ef ffe fe ect ct cts s s of of of T T TGC GC G o o on n n ot o her outcomes across age su ub bg bgr ro oups using exa xa act c log og gi is istic regression for binary outc c com o es, exac act t Po ois ss so on n n re re regr gr re es essi sio on on f fo or r c c coun n nt outc c co om me es s o or r r r rate te t s, s, C Cox x p p pro o opo por rt rti io iona nal l l ha ha haza za ard d ds s e egr gr gres es ssi si s on on f f for o or t tim im me e-e-to to--ev ve vent nt o o out ut utco co come me m s, s, , a a and nd nd l l lin n ne e ear ar r re eg egr re ress ss ssio io ion n fo fo for r co co ont nt ntin in nuo o ous us o o out ut utco co ome me m s. . T To To explore othe er r po po pote te ent nt ntia ia al l l pr pr p ed ed dic ic cto tors rs rs o of f f in infe fe fect ct ctio io on, n, n, m m mul ul ulti ti iva va v ri ri iab ab able le le s ste te tepw pw p is is ise e e lo lo logi gi gist st stic ic r r reg eg egre re ress ss sio i n was Table 1) . Though the point estimates suggested a possible harmful effect of TGC in neonates (age 30 days at surgery) and a possible benefit of TGC in patients who did not receive intraoperative glucocorticoids, neither effect was statistically significant at the 0.05 level (P=0.07 and P=0.09, respectively).
Given the observed heterogeneity of treatment effect by age at surgery, we next sought to determine empirically an optimal age cutoff. We explored this by running logistic regression models that included the main effects of treatment group and age subgroup and the interaction term as covariates, where age subgroup was defined using different cutoffs from 30 days to 12 months ( Figure 1 ). Plotting the log likelihood from these models versus age cutoff demonstrated that an age cutoff of 59 days (95% confidence interval 55-71 days via the likelihood ratio test) best discriminated two age subgroups with differential risk of infection based on treatment arm. The difference in model characteristics was negligible when comparing models using an age cutoff of 59 days vs. 60 days, so for subsequent analyses and ease of reporting we defined the age subgroups as those 60 days or >60 days at the time of surgery.
The comparison of the infection outcome between treatment groups within the empirically derived age subgroups is shown in Table 2 . The rate and incidence of healthcareassociated infections in subjects 60 days of age were significantly increased among those in the TGC group compared to the STD group (rate 13.5 vs. 3.7 infections/1,000 CICU days, P=0.01; incidence 13% vs. 4%, P=0.02), while the rate and incidence of infections among those >60 days of age were significantly reduced in the TGC group compared to the STD group (rate 5.0 vs. models that included the main effects of treatment group and age subgroup and th th he in in i te te tera a ract ct ctio io ion n erm as covariates, where age subgroup was defined using different cutoffs from 30 days to 12 based on treat at tme me m nt nt nt a a arm rm m. . T T The he he dif if iffe fe fere re enc nc ce e e in in in m m mod od odel el l c c cha ha hara ract ct cter er eris is sti ti ics cs cs w was as a n n neg eg egli li ligi gi g bl bl le e e wh wh when en en comparing g g 14.1 infections/1,000 CICU days, P=0.02; incidence 2% vs. 5%, P=0.03). The treatment group by age subgroup interactions were highly significant (P=0.001 for each). These analyses did not appreciably change with adjustment for site. There was a differential treatment group by age subgroup effect across the four CDC-defined infection types.
In light of the opposing effects of treatment on infection in the two age subgroups, 60 days and 60 days to 3 years, we did not find any statistically significant differences in the baseline characteristics between treatment groups across the age subgroups, as detailed in nfections/1,000 CICU days in 2,035 patients >60 days; P<0.001).
Supplemental
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Secondary study outcomes were largely similar between treatment groups across the age subgroups with the exceptions of cardiac index and red blood cell transfusions, as shown in ntubated on post-operative day 2), there were no differences between treatment t g g grou o o ps ps ps i i in n n mortality, length of CICU or hospital stay, length of vasoactive support, or transfusions in the >6 60 0 0 da da day ys ys s s sub ub ubg grou ou up p. p.
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Although intraoperative glucocorticoid use differed by age (71% subjects 60 days received glucocorticoids vs. 45% subjects >60 days; P<0.001), further adjustment for intraoperative glucocorticoid use did not appreciably affect these results. Similarly, further adjustment for site did not appreciably affect the results.
Discussion
In this exploratory analysis of our study cohort from a large randomized controlled trial of tight glycemic control we found differential response to the intervention among patients 60 days versus those >60 days of age at the time of surgery. Our analysis suggests that younger patients had an increased rate of healthcare-associated infections with TGC compared to STD while the older patients had a lower rate with TGC compared to STD. There is a history of younger children having increased mortality with insulin therapy in the NIRTURE trial. 21 The NIRTURE study was ongoing at the time of the design of our trial and was subsequently halted early due to potential for harm in the treatment group. Other TGC trials in children [22] [23] [24] have not reported analyses of the interaction of treatment group with age subgroups.
To our knowledge, there are no other data suggesting a 60-day age cutoff for differential response to TGC. It is conceivable that TGC confers benefits that have more relevance to the older child whose maternally-acquired, antibody-mediated immunity has waned, 25, 26 as opposed to the infant who also may be more susceptible to protocol-associated hypoglycemia and anemia. 27, 28 These theories will remain speculative, however, until further data can be analyzed confirming the presence of a differential effect above and below 60 days of age in other TGC trial populations.
Upon initial examination of our data, there appeared to be a low rate of infection in the had an increased rate of healthcare-associated infections with TGC compared to o ST ST STD D wh wh whil il ile e e th the e older patients had a lower rate with TGC compared to STD. There is a history of younger ch hil il ldr dr dren en en h h hav av avin ing in in inc cr creased mortality with insulin n n th th t e e erapy in the N NIR IR IRTU U URE RE RE trial. 21 The NIRTURE t tud d dy y was ongo goin in ing g g at at t the he e t t tim im ime e of of t t th h he e e d de es sign of f f ou ur r t t tria al l l a an and d d w wa was s su ub ubse sequuen entl tl ly y y ha halt lt ted ed d e ea a arly ly y d d due ue ue to po pote te tent nt ntia ia i l l fo fo or r r h ha harm rm m i in n t th the e e tr trea atm tm tmen en ent t t g gr grou ou up. p. p O O Othe he her r TG TG TGC C C tr r ria ia ials ls ls i in n n ch ch hil il ldr dr dren en n 2 22 22-24 24 4 h ha av ave e no no not r re epo po port rte ed ed analyses of th th he e e in in i te te tera ra r ct ct c io io i n n of of of t trea ea eatm tm tmen e e t t t gr gr grou ou oup p p wi wi w th th th a a age g g s s sub ub ubgr gr grou ou oups ps p .
patients randomized to the STD arm in the younger age subgroup. These patients typically have more complex surgery, higher rates of delayed sternal closure, greater exposure to intravenous catheters, and longer CICU stays, and thus might be expected to have a higher infection rate than older infants and children. In order to determine whether the low rate of infection observed in STD subjects 60 days old was related to the study procedures used, we evaluated historical data from non-study patients treated in the Boston Children's Hospital CICU. These rates, assessed over the years 2005 to 2012 and previously unpublished, showed similar trends to the rates seen in SPECS. We concluded that the relationship between infection rates in younger ( 60 days) compared to older patients observed in the STD arm of the SPECS trial was consistent with historical trends.
The striking interaction between treatment group and age subgroup on infection rates led us to investigate other clinical outcomes to further explore the benefits of TGC in the older patients. We observed that patients >60 days treated with TGC had significantly higher cardiac index on post-operative day 2 compared to those in the STD arm, though the interaction between treatment group and age subgroup on this outcome was not statistically significant. This analysis was limited to those in the Boston Children's Hospital CICU with a central venous catheter in the superior vena caval circulation, and who remained intubated on the second post-operative day, as the measurement of oxygen consumption was conducted via the ventilator exhalation valve. Though it is a smaller subset of the overall cohort (N=191), this group of patients, due to higher illness severity, may be most likely to derive benefit from TGC if benefit exists.
Both in vitro studies and prior clinical reports [29] [30] [31] [32] demonstrate the potential benefits to the myocardium of controlling blood glucose with insulin infusion, specifically in mitigating the effects of ischemia-reperfusion injury. Improved myocardial recovery should lead to other historical trends.
The striking interaction between treatment group and age subgroup on infection rates led us s t t to o o in in inve vest st stig ig igat a e e ot ot othe h r clinical outcomes to furthe he her r e explore the be ene n n fits ts s o o of f TGC in the older pati i ien e ts. We ob ob bse se s rv rved ed ed t t tha ha hat t t pa pa pat ti tien en nts ts ts > >6 60 60 day y ys trea a ate ed w wi wit th th T T TG GC GC ha ha ad d si si ig gn gnif ific ic can an ntl tly y hi hi high gh ghe e er c c car ardi di d a a ac n nde de dex x x on on o p p pos os ost t-t-op op per r rat ativ iv ve e da day 2 2 2 co co omp mp mpar are ed ed t t to o o t t thos os ose e in in t th he e S S STD TD TD a a arm rm rm, th th thou ou ough gh h t the he he i i int nt n er er rac ac actio on on b bet etwe we ween e reatment grou ou up p p an an nd d d ag ag age e e su u ubg bg bgro ro oup up up o o on n n th th his is s o o out ut utco co come me me w w was as no no not t t st st s at at atis is isti t ca ca call ll lly y y si si sign gn gnif ific ic ican an ant. t. . Th T T is analysi is important outcome differences, but we observed similar durations of mechanical ventilation, vasoactive support, and CICU and hospital length of stay between treatment arms in the >60 days subgroup. However, these outcomes were calculated for the entire >60 days subgroup, so it may be that only those patients with greater post-operative organ dysfunction (e.g., those mechanically ventilated greater than 48 hours) reap the benefits of TGC. Further analysis of past and ongoing pediatric TGC clinical trials, focusing on patients with the greatest illness severity, may elucidate the possible benefits of TGC to cardiopulmonary recovery.
Younger patients in the TGC arm also had a higher transfusion rate compared to the STD arm, and there was a trend toward a significant interaction between treatment group and age subgroup on transfusion (P=0.058). The increased transfusion rate in the TGC subjects in the 60 days cohort is likely a reflection of the increased frequency of blood glucose sampling in the overall TGC cohort compared with STD. Given the smaller body mass and circulating blood volume in the 60 days cohort, a similar volume of blood drawn would represent a greater relative amount of blood loss, possibly leading to an increased transfusion rate. This would explain why the same difference in number of blood draws was not associated with increased transfusion rate in the older cohort. We attempted to mitigate this effect in the trial design by using a blood conservation device as well as a bedside glucose meter that required small amounts of blood.
There are important limitations to the findings reported in this manuscript. Most importantly, these are exploratory findings based on our initial observation that statistically significant interactions existed between treatment group and age subgroup on rate and incidence of infection. Although there is biologic plausibility for differential immune function at 60 days of age, the age cutoff we report here has not been suggested before in the critical care or TGC ubgroup on transfusion (P=0.058). The increased transfusion rate in the TGC s su ub ubje je j ct ts s s in in in t t the h he 60 days cohort is likely a reflection of the increased frequency of blood glucose sampling in the ov ver er eral al all l l TG TG TGC C C c coho ho hor rt rt compared with STD. Given n n th the e smaller body y y mas ass s s a an and circulating blood v volu u ume m in the e 60 60 6 d day ay ys co co coho ho hort rt t, a a si si s m m mil l lar r r volu lu l m m me o o of f f bloo oo ood d d d dra aw awn n n w wo woul ul ld d d r re repr pr res esen ent t t a gr gr g e e eate te ter r e ela la lati ti ive ve ve a amo mo mou un unt t of of of b blo lo ood od d l los o s, s, s, p p pos os ossi si sib bl bly y y le le ead ad adi in ing g g to to a an n n in in ncr cr rea ea ease se ed d d tr tr ran n nsf sf sfus us sio o on n ra ra rate te e. . T T Thi hi his wo wo woul uld d explain why y th th he e e sa sa ame me m d d dif i i fe fe ere re renc nc n e e e in in i n n num m mbe be ber r r of of of bl bl b oo oo ood d d dr draw aw aws s s wa wa was s s no no n t t t as as asso so soci ci ciat at ated ed d w w wit it ith h h in in increased clinical literature. Some strengths of our analysis, however, are that this secondary analysis showed a statistically significant treatment group with age subgroup interaction on our primary outcome variable, the 95% confidence interval for the optimal age cutoff was fairly tight (55-71 days), and the characteristics of our STD cohort are consistent with a historical CICU population.
We have conducted our analysis and reported the findings in accordance with guidelines recommended by other authors for subgroup analyses of randomized clinical trials. 20, 33 To remain consistent with these recommendations, the findings herein should be interpreted conservatively. The results are appropriately considered hypothesis-generating, rather than confirmatory. It will be crucial to evaluate whether patients greater than 60 days of age demonstrate benefit from TGC in analyses of recent and ongoing clinical trials in the context of a planned meta-analysis. However, based on the overall null finding in the trial, and the results of this analysis, we would not recommend post-operative TGC for patients 60 days of age who undergo cardiac surgery. TGC denotes Tight Glycemic Control, STD Standard Care, CI confidence interval, RACHS-1 Risk Adjustment in Congenital Heart Surgery, and CICU cardiac intensive care unit. * Healthcare-associated infections include pneumonia, bloodstream, and urinary tract infections, which were tracked for up to 30 days in the CICU or until 48 hours after discharge from the CICU, and surgical site infections, which were tracked for 30 days after the index procedure. For patients who remained in the CICU for more than 30 days, the number of patient-days in the CICU was considered to be 30. † The P values for the interaction between treatment group and risk factor were calculated from logistic regression models including the main effects and interaction term as covariates.
‡ The scale for RACHS-1 categories ranges from 1 to 6, with higher categories indicating greater risk. (4) 4) TGC denotes Tight Glycemic Control, STD Standard Care, CI confidence interval, and CICU cardiac intensive care unit. * The P values for the interaction between treatment group and age subgroup were calculated from logistic regression models for the proportion of subjects with any infection or exact Poisson regression models for the number of infections and 30-day infection rate. These models included the main effects and interaction term as covariates. † Healthcare-associated infections include pneumonia, bloodstream, and urinary tract infections, which were tracked for up to 30 days in the CICU or until 48 hours after discharge from the CICU, and surgical site infections, which were tracked for 30 days after the index procedure. For patients who remained in the CICU for more than 30 days, the number of patient-days in the CICU was considered to be 30. de eno note te t s Ti Ti Tigh gh ght t Gl Gl Glyc yc ycem emic ic C C C n n ontr trol ol, , ST STD D D St Standa da dard C C Car ar a e, e, , C CI I o co conf nf d id iden en ence ce ce int nt nter er erva val, l l a and n n C C CIC ICU U U c c car ar ardiac ac ac i int nten e si i sive ve ve c c r ar are n un u it it. . P val alue ues s f fo for r th th the in intera act ctio ion be betw twee e n tr trea eatm t en ent t gr grou oup p an a d age e su subg bg b ro roup up w wer ere e cal lcul ulat at d ed ed f fro rom m lo logi g stic r reg eg e ress ssio ion mo mode dels ls f for or t t the he h pr P op opor o ti tion on o of f su s bj bjec ects ts fe fe fect ct ctio io ion n n or or or e e exa xa xact ct ct P P Poi oi oiss ss sson on on r r reg eg egre re ress ss ssio io ion n n mo mo mode de dels ls ls f f for or or t t the he he n n num um umbe be ber r r of of of i i inf nf nfec ec ecti ti tion on ons s s an an and d d 30 30 30-d -d day ay ay i i inf nf nfec ec ecti ti tion on on r r rat at ate e. e. T T The he hese se se m m mod od odel el els s s in in incl cl clud ud uded ed ed f f f th th the e e ma ma main in in e e eff ff ffec ec ects ts ts a a and nd nd i i int nt nter er erac ac a s covariates. * The P values for the interaction between treatment group and age subgroup were calculated from logistic regression models for binary outcomes, Cox proportional hazards regression models for time-to-event outcomes, or a linear regression model for cardiac index. These models included the main effects and interaction term as covariates. † Eight patients were lost to follow-up between hospital discharge and study day 30. ‡ The duration of the stay in the CICU, the stay in the hospital, and mechanical ventilation were considered to be 30 days for patients with duration of more than 30 days and for the 11 patients who died in the CICU by the 30 th day. § The cardiac index on day 2 was measured in 191 patients at Boston Children's Hospital. sive care unit it, , and d IQ IQR R i int terqua t rtil ile range. P values for the in nte te t ra ra ract ct ctio io ion n n be be betw tw twee ee e n n n tr tr a a eatm tm tmen en ent r gr u ou oup p p an n a d d d g ag age e e su su ubg bg b o ro r up up up w w wer er e e e ca ca calc lc cul ul u t ated ed d f fro rom m m lo lo l gi gi gist t stic ic i r g eg egre re r ss ss ssio o ion n n mo mo mode de d s ls f f for or o b b bin in nar ar ry y y P o o out u comes, Cox y y ti tion onal al h haz azar ards ds r reg egre ress ssio ion n mo mode dels ls f for or t tim ime e-to to e -eve vent nt o out utco come mes s o or r a a li line near ar r reg egre ress ssio ion n mo mode del l fo for r ca card rdia iac c in inde dex x T The hese se m mod odel els s i inc nclu lude ded d th the e ma main in e eff ffec ects ts all blood glucose samples on the day of post-operative admission to the cardiac in in nte te ens nsiv iv ve e e ca ca care re r unit (CICU) (day 1) and the subsequent two days (7 a.m. to 6:59 a.m.). Panel A shows the TW W WGA GA GA b b by y y da da day fo fo or r r su s bjects 60 days old at the t t tim im ime e e of surgery, wh wh while e Pa Pa Pan nel B shows the TWGA b by y d d day a for sub bje jec ct c s s s >6 >6 >60 da da days ys ys o o old ld. Th Th The e po po oints s s r r repre e es se ent t t th he he m m med ed e ia ia an ns s, wh wh whil le e th th he e e er erro ro or ba ba bar r rs e e ext xten en end d to h he e e 25 25 25th th t a and nd nd 7 7 75t 5th h h p pe perc rc cen n nti tile l s. s. N N NS S S de de deno no ote te es s s no no not si si sign gn gnif f fic i an an ant. t t.
